ClinicalTrials.gov record
Completed No phase listed Observational

Bipolar Proteomic Assay Validation Study

ClinicalTrials.gov ID: NCT02746367

Public ClinicalTrials.gov record NCT02746367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Validation Study to Measure the Impact of a Proteomic Assay in Distinguishing Bipolar I Disorder, Bipolar II Disorder, and Major Depressive Disorder in People Presenting With a Major Depressive Episode

Study identification

NCT ID
NCT02746367
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Myriad Genetic Laboratories, Inc.
Industry
Enrollment
261 participants

Conditions and interventions

Interventions

  • Diagnostic test (LDT) Other

Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2016
Primary completion
Nov 7, 2018
Completion
Nov 7, 2018
Last update posted
May 13, 2020

2016 – 2018

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
University of Iowa Health Care, Department of Psychiatry Iowa City Iowa 52242
University of Minnesota (UMN) Department of Psychiatry Minneapolis Minnesota 55414
Lindner Center of HOPE/University of Cincinnati College of Medicine Mason Ohio 45040
University of Pittsburgh Western Psychiatric Institute and Clinic Pittsburgh Pennsylvania 15213
University of Texas Health Science Center San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02746367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02746367 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →